These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28391312)

  • 1. Calcium-based phosphate binders; down, but not out.
    Elder GJ
    Nephrol Dial Transplant; 2017 Jan; 32(1):5-8. PubMed ID: 28391312
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium-based phosphate binders are appropriate in chronic renal failure.
    Friedman EA
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):704-9. PubMed ID: 17699276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphate binders: hold the calcium?
    Bushinsky DA
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):695-6. PubMed ID: 17699274
    [No Abstract]   [Full Text] [Related]  

  • 4. A new era in phosphate binder therapy: what are the options?
    Salusky IB
    Kidney Int Suppl; 2006 Dec; (105):S10-5. PubMed ID: 17136110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of hyperphosphatemia beyond phosphate.
    Evenepoel P
    Kidney Int; 2007 Mar; 71(5):376-9. PubMed ID: 17315005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case against calcium-based phosphate binders.
    Moe SM; Chertow GM
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):697-703. PubMed ID: 17699275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparison of phosphorus-chelating effect of calcium carbonate versus calcium acetate before dialysis].
    Borrego J; Pérez del Barrio P; Serrano P; García Cortés MJ; Sánchez Perales MC; Borrego FJ; Liébana A; Gil Cunquero JM; Pérez Bañasco V
    Nefrologia; 2000; 20(4):348-54. PubMed ID: 11039260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lanthanum carbonate as a first-line phosphate binder: the "cons".
    Drüeke TB
    Semin Dial; 2007; 20(4):329-32. PubMed ID: 17635823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of magnesium binders in chronic kidney disease.
    Spiegel DM
    Semin Dial; 2007; 20(4):333-6. PubMed ID: 17635824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of short-term magnesium carbonate treatment on calcium-phosphorus balance in dialysis patients].
    Zwiech R; Dryja P; Łacina D; Króliczak V; Chrul S; Kacprzyk F
    Wiad Lek; 2011; 64(1):9-14. PubMed ID: 21812357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lanthanum carbonate--a first line phosphate binder?
    de Freitas D; Donne RL; Hutchison AJ
    Semin Dial; 2007; 20(4):325-8. PubMed ID: 17635822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorus management in end-stage renal disease.
    Finn WF
    Semin Dial; 2005; 18(1):8-12. PubMed ID: 15663754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidden phosphorus in popular beverages.
    Murphy-Gutekunst L
    Nephrol Nurs J; 2005; 32(4):443-5. PubMed ID: 16180787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of calcium-phosphorus metabolism in patients with chronic renal failure on hemodialysis treatment].
    Pérez Ruilópez MA; Damiano Rivero A; Herrerías Echabe JM; Garrido Peralta M
    Rev Iber Endocrinol; 1976; 23(138):535-55. PubMed ID: 1013577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium and phosphorus metabolism in patients who have chronic kidney disease.
    Goodman WG
    Med Clin North Am; 2005 May; 89(3):631-47. PubMed ID: 15755471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of xidifon for the correction of phosphorus-calcium metabolism in patients in the terminal stage of chronic kidney failure who are on programmed hemodialysis].
    Konstantinova OV; Ianenko EK; Danilkov AP; Pashkin IN
    Urol Nefrol (Mosk); 1997; (3):23-5. PubMed ID: 9245050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake.
    Uribarri J
    Semin Dial; 2007; 20(4):295-301. PubMed ID: 17635818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lanthanum: new drug. Hyperphosphataemia in dialysis patients: more potential problems than benefits.
    Prescrire Int; 2007 Apr; 16(88):47-50. PubMed ID: 17458039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in the management of hyperphosphatemia in chronic kidney disease.
    McIntyre CW
    Semin Dial; 2007; 20(4):337-41. PubMed ID: 17635825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphate binders in a European haemodialysis population.
    Jean G; Vanel T
    Nephrol Dial Transplant; 2011 Jun; 26(6):2057-8; author reply 2058. PubMed ID: 21414974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.